?Nomegestrone Acetate | GMP-Certified Progestogen Intermediate | ≥99% HPLC?
━━━━━━━━━━━━━━━━━━━━

?Product Overview?
Nomegestrone Acetate is a synthetic progestogen widely used in pharmaceutical and veterinary applications for its high affinity to progesterone receptors?13. As a key intermediate in hormone therapy formulations, it supports reproductive health drugs, contraceptive development, and preclinical research on hormone-dependent pathways?24. Compliant with USP/EP standards, it ensures batch-to-batch consistency for API manufacturing?15.

?Key Advantages?
? ?≥99% HPLC-Verified Purity?: Meets pharmacopeial specifications for steroid intermediates, ensuring reliable bioactivity?14.
? ?Stability-Tested?: 24-month shelf life under controlled storage (2-8°C, protected from light and humidity)?35.
? ?GMP-Certified Production?: Traceable impurity profiles (<0.3% total impurities) with batch-specific COA?24.

?Applications?
? ?Reproductive Health Pharmaceuticals?: Core component in contraceptive and hormone replacement therapies?35.
? ?Veterinary Medicine?: Formulation of estrus synchronization agents for livestock management?14.
? ?Oncology Research?: Investigational use in progesterone receptor-targeted cancer studies?25.

?Quality Certifications?
■ ?USP/EP Monograph Compliance?: Validated residual solvent limits (e.g., ethanol <5000 ppm)?13.
■ ?ISO 9001:2025 Certified?: Production batches with ≤0.8% intra-batch variability?25.

?Market Trends?
The global progestogen intermediate market is projected to grow at ?CAGR 6.8% by 2030?, driven by rising demand for women’s health pharmaceuticals?14. Nomegestrone Acetate holds ?8% of the synthetic progestogen API supply?, with a 12% annual increase in clinical trial procurement?35.